Assessment of dyspnea early in acute heart failure: Patient characteristics and response differences between likert and visual analog scales

Academic Emergency Medicine

Volumn 21, Issue 6, 2014, Pages 659-666

  Pang, Peter S ^a   Collins, Sean P ^b   Sauser, Kori ^c,d,e   Andrei, Adin Cristian ^f   Storrow, Alan B ^b   Hollander, Judd E ^g   Tavares, Miguel ^h   Spinar, Jindrich ⁱ   Macarie, Cezar ^j   Raev, Dimitar ^k   Nowak, Richard ^l   Gheorghiade, Mihai ^a   Mebazaa, Alexandre ^m,n  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^f NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h HOSPITAL DE SANTO ANTÓNIO   (Portugal)

ⁱ UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^j Emergency Institute for Cardiovascular Diseases Prof Dr CC Iliescu   (Romania)

^k UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^l WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m HÔPITAL LARIBOISIÈRE   (France)

ⁿ UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSPNEA; FEMALE; HEART FAILURE; HUMAN; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DECISION SUPPORT TECHNIQUES; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84904022130     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12390     Document Type: Article

References (21)

1. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC,. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 2006; 47: 76-84.
2. Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46: 57-64.
3. Metra M, Cleland JG, Weatherley BD, et al. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail 2010; 12: 499-507.
4. Metra M, O'Connor CM, Davison BA, et al. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J 2011; 32: 1519-34.
5. Pang PS, Cleland JG, Teerlink JR, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008; 29: 816-24.
6. West RL, Hernandez AF, O'Connor CM, Starling RC, Califf RM,. A review of dyspnea in acute heart failure syndromes. Am Heart J 2010; 160: 209-14.
7. Allen LA, Metra M, Milo-Cotter O, et al. Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF). J Card Fail 2008; 14: 777-84.
8. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.
9. Mebazaa A, Pang PS, Tavares M, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 2010; 31: 832-41.
10. Pang PS, Konstam MA, Krasa HB, et al. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J 2009; 30: 2233-40.
11. Mentz RJ, Hernandez AF, Stebbins A, et al. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Eur J Heart Fail 2013; 15: 456-64.
12. Johnson MJ, Oxberry SG, Cleland JG, Clark AL,. Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review. Eur J Heart Fail 2010; 12: 137-47.
13. Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013; 381: 29-39.
14. Pang PS, Tavares M, Collins SP, et al. Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study. Am J Ther 2008; 15: 299-303.
15. Ander DS, Aisiku IP, Ratcliff JJ, Todd KH, Gotsch K,. Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 2004; 10: 188-91.
16. Brieman L., Bagging predictors. Machine Learn 1996; 24: 123-40.
17. Pang PS, Gheorghiade M, Dihu J, et al. Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials. Am Heart J 2011; 161: 1067-72.
18. Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials. JAMA 2007; 297: 1332-43.
19. Gheorghiade M, Ruschitzka F,. Beyond dyspnoea as an endpoint in acute heart failure trials. Eur Heart J 2011; 32: 1442-5.
20. Stevenson LW, Hellkamp AS, Leier CV, et al. Changing preferences for survival after hospitalization with advanced heart failure. J Am Coll Cardiol 2008; 52: 1702-8.
21. Collins SP, Peacock WF, Lindsell CJ, et al. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med 2009; 53: 748-57.